Related Experiment Videos

Recent advances in the preparation of plasma-derived and recombinant coagulation factor VIII

¹George Washington University School of Medicine, Children's National Medical Center, Washington, DC 20010.

The Journal of Pediatrics

|September 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2004

Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group.

Thrombosis and haemostasis·2000

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates.

Haemophilia : the official journal of the World Federation of Hemophilia·1999

Multicenter trial to evaluate the safety and potential efficacy of pooled human fibrin sealant for the treatment of burn wounds.

The Journal of trauma·1999

A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study Group.

Thrombosis and haemostasis·1997

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

Blood·1994

See all related articles